T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease
- PMID: 21491489
- DOI: 10.1002/mds.23722
T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease
Erratum in
- Mov Disord. 2012 Feb;27(2):335
Abstract
Depigmentation of the substantia nigra is a conspicuous pathological feature of Parkinson's disease and related to a loss of neuromelanin. Similar to melanin, neuromelanin has paramagnetic properties resulting in signal increase on specific T1-weighted magnetic resonance imaging. The aim of this study was to assess signal changes in the substantia nigra in patients with Parkinson's disease using an optimized neuromelanin-sensitive T1 scan. Ten patients with Parkinson's disease and 12 matched controls underwent high-resolution T1-weighted magnetic resonance imaging with magnetization transfer effect at 3T. The size and signal intensity of the substantia nigra pars compacta were determined as the number of pixels with signal intensity higher than background signal intensity+3 standard deviations and regional contrast ratio. Patients were subclassified as early stage (n=6) and late stage (n=4) using the Unified Parkinson's Disease Rating Scale and the Hoehn and Yahr Parkinson's disease staging scale. The T1 hyperintense area in the substantia nigra was substantially smaller in patients compared with controls (-60%, P<.01), and contrast was reduced (-3%, P<.05). Size reduction was even more pronounced in more advanced disease (-78%) than in early-stage disease (-47%). We present preliminary findings using a modified T1-weighted magnetic resonance imaging technique showing stage-dependent substantia nigra signal reduction in Parkinson's disease as a putative marker of neuromelanin loss. Our data suggest that reduction in the size of neuromelanin-rich substantia nigra correlates well with postmortem observations of dopaminergic neuron loss. Further validation of our results could potentially lead to development of a new biomarker of disease progression in Parkinson's disease.
Copyright © 2011 Movement Disorder Society.
Similar articles
-
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.Neuroreport. 2006 Jul 31;17(11):1215-8. doi: 10.1097/01.wnr.0000227984.84927.a7. Neuroreport. 2006. PMID: 16837857
-
Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.Eur J Neurol. 2015 Mar;22(3):540-6. doi: 10.1111/ene.12613. Epub 2014 Dec 22. Eur J Neurol. 2015. PMID: 25534480
-
Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease.J Clin Neurosci. 2011 Aug;18(8):1093-6. doi: 10.1016/j.jocn.2010.08.043. Epub 2011 Jun 29. J Clin Neurosci. 2011. PMID: 21719292
-
Magnetic resonance imaging of the substantia nigra in Parkinson's disease.Mov Disord. 2012 Jun;27(7):822-30. doi: 10.1002/mds.25015. Epub 2012 May 30. Mov Disord. 2012. PMID: 22649063 Review.
-
7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.Mov Disord. 2014 Nov;29(13):1574-81. doi: 10.1002/mds.26043. Epub 2014 Oct 12. Mov Disord. 2014. PMID: 25308960 Review.
Cited by
-
Impact of Locus Coeruleus and Its Projections on Memory and Aging.Brain Connect. 2022 Apr;12(3):223-233. doi: 10.1089/brain.2020.0947. Epub 2021 Sep 3. Brain Connect. 2022. PMID: 34139886 Free PMC article.
-
Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.Neuroimage Clin. 2020;28:102391. doi: 10.1016/j.nicl.2020.102391. Epub 2020 Aug 20. Neuroimage Clin. 2020. PMID: 32889398 Free PMC article.
-
Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait.Front Aging Neurosci. 2023 Feb 2;15:1060935. doi: 10.3389/fnagi.2023.1060935. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36819729 Free PMC article.
-
Diagnostic performance of a high-spatial-resolution voxelwise analysis of neuromelanin-sensitive imaging in early-stage idiopathic Parkinson's disease.BMC Med Imaging. 2023 May 18;23(1):64. doi: 10.1186/s12880-023-01018-1. BMC Med Imaging. 2023. PMID: 37202720 Free PMC article.
-
Cohort profile: the Oxford Parkinson's Disease Centre Discovery Cohort MRI substudy (OPDC-MRI).BMJ Open. 2020 Aug 13;10(8):e034110. doi: 10.1136/bmjopen-2019-034110. BMJ Open. 2020. PMID: 32792423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous